Joseph M. Scandura

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

Joseph M. Scandura

Mar 27, 2025, 07:24 | Drugs

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis - Mount Sinai Department of Medicine

Mount Sinai Department of Medicine shared a post on LinkedIn: "John Mascarenhas, MD, discusses his…

Dec 8, 2024, 06:21 | Insight

Understanding and treating myelofibrosis

Nico Gagelmann shared a post on X: "Understanding and treating myelofibrosis A short thread on…

Aug 27, 2024, 21:59 | Blog

Hear about the translational aspects of Myeloproliferative neoplasms from Joseph Scandura - VJHemOnc

The Video Journal of Hematology and Hematological Oncology shared a post on X: "Earlier, we…

May 1, 2024, 08:43 | Insight

Naveen Pemmaraju: It’s time to talk about revised endpoints for Myelofibrosis clinical trials

Naveen Pemmaraju shared on X/Twitter: "It’s time to talk about revised endpoints for Myelofibrosis clinical…

All: 4 Posts: 1 - 100

'

Garo Armen Shares a Personal Story Driving Agenus' Mission in Cancer Care

'

Dr. Oliver Bogler, PhD: Leaving the National Cancer Institute

'

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care

'

Sibylle Loibl: Final survival Results from the PENELOPE-B trial published in Annals of Oncology

'

Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023